CA21116 - Identification of biological markers for prevention and translational medicine in pancreatic cancer (TRANSPAN)
Pancreatic cancer (PC) has a high mortality rate and is projected to become a massive public health problem in Europe. This Action will boost research on prevention of PC, particularly in the discovery of genetic risk factors, risk stratification, identification of biomarkers for early detection and patient monitoring, elucidation of biological mechanisms and functional pharmacogenomics for personalized medicine. These aims will be attained by expanding an existing interdisciplinary network.
CA20140 - CorEuStem: The European Network for StemCell Core Facilities (CorEuStem)
The COST Action CorEuStem – The European Network for Stem Cell Core Facilities iscomprised by experts in stem cell biology, differentiation, organoids and gene editing technologies with the aim of developing an efficient and effective consortium for harmonizing procedures and protocols across Europe and beyond. CorEuStem consortium seeks to become a Pan European reference point for stakeholders in stem cell biology and associated technologies.
CA20124 - Maximising impact of multidisciplinary research in early diagnosis of neonatal brain injury (AI-4-NICU)
The AI4NICU Action will create a pan-European multidisciplinary network with the clinical and technical expertise required to bring artificial intelligence (AI)-enabled decision-support tools to the neonatal intensive care unit (NICU). These AI tools build on existing cot-side technologies, such as the electroencephalogram, by including machine-learning algorithms to detect biomarkers of brain injury.
